Platelet-dependent thrombin generation in patients with diabetes mellitus: effects of glycemic control on coagulability in diabetes
I Aoki,
K Shimoyama,
N Aoki,
M Homori,
A Yanagisawa,
K Nakahara,
Y Kawai,
SI Kitamura,
and
K Ishikawa
Second Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.
OBJECTIVES: This study sought to assess the usefulness of platelet-dependent thrombin generation as an index of coagulability in diabetes and to determine the effect of glycemic control on coagulability in diabetes. BACKGROUND: It is important to investigate the interaction of platelets and the coagulation factors to clarify the processes of the coagulation system in detail. METHODS: Platelet-rich plasma (150 X 10(9)/liter), 0.5 ml, was prepared, and 40 mmol/liter of calcium chloride was added to initiate clotting. S-2238 was added to each sample in a microtiter plate every 10 min, and the absorbance of the released color product at 2 min was measured spectrophotometrically at a wavelength of 405 nm using a microtiter plate reader as thrombin generation. We measured the platelet-independent thrombin generation in patients with non-insulin-dependent diabetes mellitus grouped according to glycemic control. RESULTS: Platelet-dependent thrombin generation at 30 min after calcium chloride addition was significantly higher in 23 patients with poorly glycemic-controlled non-insulin-dependent diabetes mellitus without complications, such as diabetic retinopathy, nephropathy and neuropathy (hemoglobin [Hb] A1c >/= 9.0%) than in 46 healthy normal subjects (448 +/- 75 vs. 165 +/- 28 mU/min, p < 0.001). Thrombin generation in 31 well controlled diabetic patients without complications (Hb A1c < 9.0%) was intermediate (240 +/- 72 mU/min) between those of the poorly controlled group and healthy normal subjects. Platelet-poor plasma from diabetic patients increased platelet-dependent thrombin generation in normal subjects. CONCLUSIONS: Coagulability is evidently enhanced in patients with non-insulin-dependent diabetes mellitus compared with that in healthy normal subjects on the basis of assessments of the platelet-dependent thrombin generation, and good glycemic control may help to correct a hypercoagulable state in diabetic patients.
This article has been cited by other articles:

|
 |

|
 |
 
F. Feit, S. V. Manoukian, R. Ebrahimi, C. V. Pollack, E. M. Ohman, M. J. Attubato, R. Mehran, and G. W. Stone
Safety and Efficacy of Bivalirudin Monotherapy in Patients With Diabetes Mellitus and Acute Coronary Syndromes: A Report From the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) Trial
J. Am. Coll. Cardiol.,
April 29, 2008;
51(17):
1645 - 1652.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. L. Air and B. M. Kissela
Diabetes, the Metabolic Syndrome, and Ischemic Stroke: Epidemiology and possible mechanisms
Diabetes Care,
December 1, 2007;
30(12):
3131 - 3140.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. I. Worthley, A. S. Holmes, S. R. Willoughby, A. M. Kucia, T. Heresztyn, S. Stewart, Y. Y. Chirkov, C. J. Zeitz, and J. D. Horowitz
The Deleterious Effects of Hyperglycemia on Platelet Function in Diabetic Patients With Acute Coronary Syndromes: Mediation by Superoxide Production, Resolution With Intensive Insulin Administration
J. Am. Coll. Cardiol.,
January 23, 2007;
49(3):
304 - 310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Carr Jr, M. H. Hackney, S. J. Hines, S. P. Heddinger, S. L. Carr, and E. J. Martin
Enhanced Platelet Force Development Despite Drug-Induced Inhibition of Platelet Aggregation in Patients with Thromboanglitis Obliterans: Two Case Reports
Vascular and Endovascular Surgery,
November 1, 2002;
36(6):
473 - 480.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hasumura, N. Aoki, K. Kawano, M. Homori, A. Maki, Y. Hioki, K. Ishikawa, and H. Yoshino
Platelet-Dependent Thrombin Generation in Patients with Unstable Angina Pectoris
Angiology,
December 1, 2001;
52(12):
811 - 818.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Hjemdahl
Smoking, nicotine and thrombotic risk -- a role for platelet dependent thrombin generation?
Eur. Heart J.,
January 1, 2001;
22(1):
16 - 18.
[PDF]
|
 |
|

|
 |

|
 |
 
L. H. Kuller, P. Velentgas, J. Barzilay, N. J. Beauchamp, D. H. O Leary, and P. J. Savage
Diabetes Mellitus : Subclinical Cardiovascular Disease and Risk of Incident Cardiovascular Disease and All-Cause Mortality
Arterioscler Thromb Vasc Biol,
March 1, 2000;
20(3):
823 - 829.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Shechter, C. N. Bairey Merz, M. J. Paul-Labrador, and S. Kaul
Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease
J. Am. Coll. Cardiol.,
February 1, 2000;
35(2):
300 - 307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Gaster and I. B. Hirsch
The Effects of Improved Glycemic Control on Complications in Type 2 Diabetes
Arch Intern Med,
January 26, 1998;
158(2):
134 - 140.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|